Diversity Action Plans in Clinical Trials

被引：0
作者：
Metcalfe, Rebecca K. [1 ]
Park, Jay J. H. [2 ]
机构：
[1] Univ British Columbia, Ctr Adv Hlth Outcomes, Vancouver, BC, Canada
[2] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 2C 1280 Main St, Hamilton, ON L8S 4L8, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 21期
关键词：
D O I：
10.1001/jama.2024.16009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This Viewpoint discusses the US Food and Drug Administration's upcoming mandate on diversity actions plans for trial sponsors and the importance of developing accountability mechanisms to monitor those plans.
引用
收藏
页码：1785 / 1786
页数：2
相关论文
共 50 条
[41]   Reimagining diversity in multiple myeloma clinical trials [J].
Habr, Dany ;
Corsaro, Massimo .
HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) :689-694
[42]   Diversity and Inclusion in Clinical Trials Are Preconditions for Equity [J].
Schmaling, Karen B. .
CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE, 2022, 29 (02) :94-96
[43]   Diversity in multiple myeloma clinical trials. [J].
Duma, Narjust ;
Velez, Miguel Gonzalez ;
Vera-Aguilera, Jesus ;
Parrondo, Richardo ;
Mariotti, Veronica ;
Paludo, Jonas ;
Wang, Yucai ;
Go, Ronald ;
Adjei, Alex .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) :68-68
[44]   Diversity in Dermatology Clinical Trials A Systematic Review [J].
Charrow, Alexandra ;
Di Xia, Fan ;
Joyce, Cara ;
Mostaghimi, Arash .
JAMA DERMATOLOGY, 2017, 153 (02) :193-198
[45]   Statistical analysis plans (SAPS) for academic clinical trials at the edinburgh clinical trials unit: what should they contain? [J].
Aryelly Rodriguez ;
Steff Lewis ;
Gordon Murray ;
Ashma Krishan ;
Isabella Butcher ;
Christopher Weir .
Trials, 14 (Suppl 1)
[46]   TRIALS AND TRIBULATIONS: DIVERSITY AND INCLUSION IN PANCREATIC DUCTAL ADENOCARCINOMA CLINICAL TRIALS [J].
Herremans, Kelly M. ;
Riner, Andrea N. ;
Hughes, Steven J. ;
Trevino, Jose G. .
GASTROENTEROLOGY, 2021, 160 (06) :S903-S903
[47]   Systematic review of randomized controlled trials examining written action plans in children [J].
Zemek, Roger L. ;
Bhogal, Sanjit Kaur ;
Ducharme, Francine M. .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2008, 162 (02) :157-163
[48]   DEOXYSPERGUALIN - MODE OF ACTION AND CLINICAL-TRIALS [J].
SUZUKI, S .
IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS, 1993, 696 :263-269
[49]   Underrepresentation of the elderly in clinical trials, time for action [J].
van Marum, Rob J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (10) :2014-2016
[50]   Lack of transparency in clinical trials: a call for action [J].
Ramirez, Jorge H. .
COLOMBIA MEDICA, 2013, 44 (04) :236-238
12345